Regenerated oxidized cellulose composite hemostatic material and preparation method thereof

By adding modified chitosan, modified starch and calcium alginate fiber to the oxidized regenerated cellulose hemostasis material, combined with ethanol pretreatment and nanosilver technologies, the problem of poor viscosity of oxidized regenerated cellulose hemostasis material is solved, significantly improving the It achieves hemostasis efficiency and material stability, and achieves good compatibility and antibacterial properties with human tissues.

CN118892570APending Publication Date: 2024-11-05QINGDAO ZHONGTENG BIOTECH
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410929973.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

The poor viscosity of existing oxidized regenerated cellulose hemostasis materials leads to low hemostasis efficiency, and the improvement of the hemostasis performance of modified materials is often accompanied by a decrease in viscosity, affecting wound healing.

Method used

Using regenerated oxidized cellulose composite materials, including modified chitosan, modified starch and calcium alginate fibers, the material stability is improved by ethanol pretreatment, and quaternary ammonium is produced by reaction of acetic acid solution and glycidyl chloride trimethylammonium chloride. Chitosan, nanosilver and polycarbonate fiber are added to form antibacterial and high-strength modified chitosan, combined with modified gelatin and microcrystalline cellulose, to form a crosslinked structure to improve the mechanical properties of the material and hemostatic effect.

Benefits of technology

Improve the mechanical properties and hemostatic effect of regenerated oxidized cellulose, enhance compatibility with human tissues, reduce rejection and infection risks, achieve rapid formation of gel-like substances to control bleeding, and provide stable physical pressure to Maintaining blood clots significantly improves the comprehensive performance of hemostatic materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004939339020000101
    Figure BDA0004939339020000101
  • Figure BDA0004939339020000111
    Figure BDA0004939339020000111
Patent Text Reader

Abstract

The invention relates to the technical field of medical supplies, and particularly discloses a regenerated oxidized cellulose composite hemostatic material and a preparation method thereof. The regenerated oxidized cellulose composite hemostatic material is prepared from the following raw materials: 10 to 15 parts of regenerated oxidized cellulose, 6 to 10 parts of modified chitosan, 7 to 11 parts of modified starch and 4 to 8 parts of calcium alginate fiber. The regenerated oxidized cellulose composite hemostatic material prepared by the invention has better mechanical property, antibacterial property, viscosity and hemostatic effect, so that the regenerated oxidized cellulose composite hemostatic material has better application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of medical supplies, and more specifically, to a regenerated oxidized cellulose composite hemostatic material and a preparation method thereof. Background Art

[0002] Oxidized regenerated cellulose is an absorbable hemostatic material in the form of cellulose acid gauze or cotton cloth that is oxidized. It has the appearance and texture of cotton yarn, is soft and thin, and is easy to wrap, stuff, etc. It has excellent biocompatibility, biodegradability and non-toxicity. It is widely used in the medical field to control bleeding, especially in surgical operations.

[0003] The most widely used oxidized cellulose hemostatic material in clinical practice is Surgicel from Johnson & Johnson in the United States. Surgicel is an absorbable hemostatic gauze whose main component is oxidized regenerated cellulose. It is non-toxic and has good biocompatibility and biodegradability. It can be completely absorbed after being implanted in the human body for 7-14 days. Its main function is to assist hemostasis when conventional hemostasis is ineffective. It has been clinically used for many years with good results, but the production process is complicated and the price is relatively expensive.

[0004] Although oxidized regenerated cellulose has many excellent properties, it also has some disadvantages, such as low hemostatic efficiency. In order to improve the promotion and application of oxidized regenerated cellulose, people are committed to studying the modification of oxidized regenerated cellulose as a hemostatic material. In the current existing technology, chitosan, alginate, graphene oxide and other composites are used to improve the hemostatic performance of oxidized regenerated cellulose, which has improved the hemostatic performance of the material to a certain extent. However, it will have a negative impact on the viscosity of the oxidized regenerated cellulose hemostatic material, making it impossible for the hemostatic material to adhere well to the wound surface, and the modification effect is not worth the loss. Summary of the invention

[0005] In order to improve the problem of poor viscosity of regenerated oxidized cellulose hemostatic materials, the present application provides a regenerated oxidized cellulose composite hemostatic material and a preparation method thereof.

[0006] In the first aspect, the present application provides a regenerated oxidized cellulose composite hemostatic material, which adopts the following technical scheme: a regenerated oxidized cellulose composite hemostatic material, comprising the following raw materials: 10-15 parts of regenerated oxidized cellulose, 6-10 parts of modified chitosan, 7-11 parts of modified starch, and 4-8 parts of calcium alginate fiber.

[0007] By adopting the above technical scheme, the regenerated oxidized cellulose can physically block the wound to prevent further blood loss, and has the ability to accelerate blood coagulation. When it comes into contact with blood, it can quickly form a gel-like substance to cover the wound and reduce bleeding. It is also well compatible with human tissues, reduces rejection reactions, and can eventually be absorbed by the body. The modified chitosan has good biocompatibility and can be loaded on the surface of the regenerated oxidized cellulose to improve the mechanical properties and hemostatic properties of the regenerated oxidized cellulose. The antibacterial property of the modified chitosan helps prevent wound infection and promote the wound healing process.

[0008] Modified starch is highly absorbent and can absorb a large amount of blood to form a gel-like substance to help control bleeding. In addition, the modified starch and modified chitosan are cross-linked to further coat the regenerated oxidized cellulose, thereby improving the hemostatic and mechanical properties of the regenerated oxidized cellulose, helping the hemostatic material to provide stable physical pressure, helping to form and maintain blood clots at the wound, and improving the hemostatic effect.

[0009] When calcium alginate fibers come into contact with wounds, they transform from a water-insoluble form into water-soluble sodium alginate to form a hydrogel, which effectively controls bleeding. Calcium alginate fibers can be loaded in a cross-linked structure formed by modified chitosan and modified starch, improving the mechanical properties of the system and allowing calcium alginate fibers to be stably loaded on the surface of regenerated oxidized cellulose. Combined with modified chitosan and modified starch, the mechanical properties, viscosity and water absorption of the regenerated oxidized cellulose are improved, and hemostasis is effective.

[0010] Optionally, the pretreatment method of the regenerated oxidized cellulose comprises the following steps: placing the regenerated oxidized cellulose in an ethanol solution, soaking for 20-25 minutes, taking it out, drying it, and then washing it with an ethanol solution for 3-4 times. After washing, taking it out and drying it to obtain pretreated regenerated oxidized cellulose.

[0011] By adopting the above technical solution, the impurities on the surface of the regenerated oxidized cellulose can be effectively removed through the ethanol cleaning treatment method, and the stability of the regenerated oxidized cellulose can be improved. The treatment process is fast and efficient, and will not have an adverse effect on the biocompatibility of the regenerated oxidized cellulose material. In addition, the application of the regenerated oxidized cellulose pretreated in the field of in vivo medical devices provides a more stable and reliable material basis.

[0012] Optionally, the method for preparing the modified chitosan comprises the following steps: (1) dispersing chitosan in an acetic acid solution, adding trimethylammonium glycidyl chloride, and heating at 70-75° C. for 8-10 hours to obtain quaternized chitosan; (2) adding nanosilver and polycarbonate fiber to the quaternized chitosan obtained in step (1), stirring at a temperature of 60-65° C. for 1-2 h, filtering, and drying to obtain a mixture; (3) Spraying the surface of the mixture obtained in step (2) with a modified gelatin solution, drying, and grinding to obtain modified chitosan.

[0013] By adopting the above technical scheme, the acetic acid solution of chitosan and trimethylammonium glycidyl chloride react to generate quaternized chitosan, which enhances the mechanical structure, solubility in water, and biodegradability of chitosan, and has better adhesion and film-forming properties; Nanosilver has antibacterial properties, inhibits the growth of bacteria in wounds, reduces the risk of infection, and enhances hemostatic effects. Polycarbonate fibers have high strength and toughness, can enhance the physical strength of hemostatic materials, and have good biocompatibility. Nanosilver can be loaded on the surface and pores of polycarbonate fibers to improve the mechanical strength, hemostatic effects, and antibacterial properties of polycarbonate fibers. Polycarbonate fibers loaded with nanosilver can be loaded in the structure of quaternized chitosan, thereby improving the mechanical properties of quaternized chitosan, while also improving the hemostatic and antibacterial effects of quaternized chitosan.

[0014] The modified gelatin solution has certain viscosity, water absorption and film-forming properties. It is sprayed on the surface of quaternary ammonium chitosan, which improves the liquid absorption performance and mechanical strength of the quaternary ammonium chitosan. At the same time, it makes the quaternary ammonium chitosan, nanosilver and polycarbonate fiber adhere tightly, making the modified chitosan stable in performance. The modified gelatin can activate platelets, induce platelet aggregation, and accelerate the blood coagulation process, thereby achieving rapid hemostasis. The various components cooperate with each other to provide better hemostasis effect and wound healing environment.

[0015] Optionally, the mass ratio of the chitosan, nanosilver, polycarbonate fiber and modified gelatin solution is 1:0.2-0.5:0.3-0.6:0.07-0.09.

[0016] By adopting the above technical scheme, the mass ratio of chitosan, nanosilver, polycarbonate fiber and modified gelatin solution is further limited within a certain range, thereby improving the mechanical properties, hemostatic effect and antibacterial property of modified chitosan, nanosilver can be loaded on the surface and pores of polycarbonate fiber, nanosilver and polycarbonate fiber can be loaded in the structure of chitosan, thereby improving the mechanical properties, antibacterial property and hemostatic effect of chitosan, and the modified gelatin solution can coat chitosan, so that the quaternized chitosan, nanosilver and polycarbonate fiber are tightly bonded, thereby further improving the comprehensive performance of modified chitosan.

[0017] Optionally, the method for preparing the modified gelatin solution comprises the following steps: dissolving gelatin in deionized water, stirring at a temperature of 80-85° C. for 1-2 hours, adding a silane coupling agent, acetic acid and microcrystalline cellulose, and continuing to stir to obtain a modified gelatin solution.

[0018] By adopting the above technical scheme, acetic acid adjusts the pH of the gelatin solution, enhances the dissolution of gelatin in water, and facilitates the subsequent reaction of gelatin with silane coupling agent and microcrystalline cellulose. The silane coupling agent forms a silicon-containing cross-linking layer on the surface of gelatin to form a more stable network structure, thereby improving the viscosity and mechanical properties of the gelatin solution, and facilitating the subsequent compounding of the gelatin solution with other materials. Microcrystalline cellulose has good viscosity and is mixed with gelatin to increase the viscosity of the gelatin solution, which facilitates the subsequent application of the gelatin solution in modified chitosan and improves the coating of the modified chitosan by gelatin. In addition, microcrystalline cellulose can be used as a skeleton material and combined with gelatin to form a porous structure, which is beneficial to improve the air permeability and absorbency of the subsequent gelatin film and facilitates the subsequent hemostatic effect of the modified chitosan.

[0019] In addition, the mixture of microcrystalline cellulose and silane coupling agent improves the physical strength and stability of the gelatin solution, and the modified gelatin formed subsequently coats the modified chitosan, so that the coated chitosan has better biocompatibility and mechanical strength.

[0020] Optionally, the mass ratio of the gelatin, the silane coupling agent and the microcrystalline cellulose is 1:0.1-0.3:0.4-0.7.

[0021] By adopting the above technical scheme, the mass ratio of gelatin, silane coupling agent and microcrystalline cellulose is further limited within a certain range, thereby improving the viscosity, mechanical strength and biocompatibility of the gelatin solution. The silane coupling agent reacts with gelatin to form a silicon-containing cross-linked layer on the surface of the gelatin, forming a more stable network structure, and improving the viscosity and mechanical properties of the gelatin solution. The mixture of microcrystalline cellulose and gelatin improves the viscosity of the gelatin solution. The mixture of microcrystalline cellulose and silane coupling agent improves the physical strength and stability of the gelatin solution. There is a synergistic effect between gelatin, silane coupling agent and microcrystalline cellulose, which are subsequently applied to modified chitosan to improve the coating of gelatin on the modified chitosan, thereby improving the mechanical strength and hemostatic effect of the modified chitosan.

[0022] Optionally, the method for preparing the modified starch comprises the following steps: (1) dispersing corn starch in a sodium hydroxide solution, stirring for 2-3 hours, centrifuging, discarding the supernatant to obtain starch milk, filtering and drying to obtain pretreated corn starch; (2) Dispersing the pretreated corn starch in step (1) in deionized water, adding nano calcium carbonate, beeswax and sodium trimetaphosphate, stirring at a temperature of 65-70° C. for 2-3 hours, filtering and drying to obtain modified starch.

[0023] By adopting the above technical scheme, corn starch and sodium hydroxide solution react to gelatinize the corn starch, which increases the solubility and viscosity of the corn starch and facilitates the subsequent application of the corn starch. Nano-calcium carbonate can be loaded in the structure of the corn starch to improve the structural strength of the corn starch, and then applied to hemostatic materials to improve the mechanical strength of the hemostatic materials, making it easier for the hemostatic materials to maintain their shape after use and providing better physical protection for wounds.

[0024] Beeswax has good waterproof, film-forming and viscosity properties. It can coat corn starch, improve the toughness of corn starch, reduce the brittleness of starch, and make the nano-calcium carbonate and corn starch more closely connected, thereby improving their physical strength and durability. In subsequent applications in hemostatic materials, beeswax can form a protective film covering the wound surface to reduce the risk of infection. Sodium trimetaphosphate helps starch to disperse more evenly in water, improves the stability of the solution system, and allows the various components in the solution system to mix evenly. Subsequently, sodium trimetaphosphate helps to improve the compatibility of hemostatic materials with human tissues, enhance the adhesion of materials to the wound surface, and maintain the stability of the material on the wound until the wound heals, thereby reducing inflammatory responses.

[0025] Preferably, the mass ratio of the corn starch, nano-calcium carbonate and beeswax is 1:0.2-0.5:0.1-0.2.

[0026] By adopting the above technical scheme, the mass ratio of corn starch, nano-calcium carbonate and beeswax is further limited within a certain range, thereby improving the mechanical strength, viscosity and film-forming properties of corn starch. Nano-calcium carbonate can be loaded in the structure of corn starch to improve the structural strength of corn starch. Beeswax coats corn starch to improve the toughness of corn starch, making the nano-calcium carbonate and corn starch more tightly connected. Subsequently, the nano-calcium carbonate is applied to hemostatic materials to improve the mechanical strength and hemostatic effect of the hemostatic materials.

[0027] In the second aspect, the present application provides a method for preparing a regenerated oxidized cellulose composite hemostatic material, comprising the following steps: adding modified chitosan, modified starch and calcium alginate fiber to deionized water, stirring for 2-3 hours at a temperature of 70-75°C to obtain a mixed solution, adding regenerated oxidized cellulose to the mixed solution, stirring for 1-2 hours, drying, and grinding to obtain a regenerated oxidized cellulose composite hemostatic material.

[0028] By adopting the above technical scheme, modified chitosan, modified starch and calcium alginate fibers are first made into a mixed liquid, and the regenerated oxidized cellulose is immersed in the mixed liquid, so that the modified chitosan, modified starch and calcium alginate fibers adhere to the surface of the regenerated oxidized cellulose, thereby improving the mechanical strength and hemostatic effect of the regenerated oxidized cellulose. The obtained regenerated oxidized cellulose has good application in the medical field.

[0029] In a third aspect, the present application provides an application of a regenerated oxidized cellulose composite hemostatic material in an in vivo medical device.

[0030] In summary, this application has the following beneficial effects: 1. The regenerated oxidized cellulose in the present application can physically block the wound to prevent further blood loss, and also has the ability to accelerate blood coagulation. When it comes into contact with blood, it can quickly form a gel-like substance to cover the wound and reduce bleeding. It is also well compatible with human tissues, reduces rejection reactions, and can eventually be absorbed by the body.

[0031] 2. The modified chitosan in the present application has good biocompatibility and can be loaded on the surface of regenerated oxidized cellulose to improve the mechanical properties and hemostatic properties of the regenerated oxidized cellulose. The antibacterial property of the modified chitosan helps prevent wound infection and promote the wound healing process.

[0032] 3. The modified starch in the present application is highly absorbent and can absorb a large amount of blood to form a gel-like substance to help control bleeding. In addition, the modified starch and modified chitosan are cross-linked to further coat the regenerated oxidized cellulose, thereby improving the hemostatic and mechanical properties of the regenerated oxidized cellulose, helping the hemostatic material to provide stable physical pressure, helping to form and maintain a blood clot at the wound, and improving the hemostatic effect. DETAILED DESCRIPTION

[0033] Preparation example of modified chitosan Preparation Example 1-1 The preparation method of modified chitosan comprises the following steps: (1) dispersing 1 kg of chitosan in 2 L of 5% acetic acid solution, adding 0.3 L of trimethylammonium glycidyl chloride, and heating at 70-75° C. for 8-10 h to obtain quaternized chitosan; (2) adding nanosilver and polycarbonate fiber to the quaternized chitosan obtained in step (1), stirring at 65° C. for 2 h, filtering, and drying to obtain a mixture; (3) Spraying the surface of the mixture obtained in step (2) with a modified gelatin solution, drying, and grinding to obtain modified chitosan.

[0034] The mass ratio of chitosan, nanosilver, polycarbonate fiber and modified gelatin solution is 1:0.2:0.3:0.07.

[0035] The preparation method of modified gelatin solution comprises the following steps: dissolving 0.7 kg gelatin in 1.5 L deionized water, stirring at 85° C. for 2 h, adding silane coupling agent, 0.1 L acetic acid and microcrystalline cellulose, and continuing stirring for 1 h to obtain modified gelatin solution.

[0036] The mass ratio of gelatin, silane coupling agent and microcrystalline cellulose is 1:0.1:0.7.

[0037] Preparation Example 1-2 The difference from Preparation Example 1-1 is that in step (2), no nanosilver is added.

[0038] Preparation Example 1-3 The difference from Preparation Example 1-1 is that in step (2), no polycarbonate fiber is added.

[0039] Preparation Example 1-4 The difference from Preparation Example 1-1 is that in step (3), the modified gelatin solution is not sprayed.

[0040] Preparation Example 1-5 The difference from Preparation Example 1-1 is that the mass ratio of chitosan, nanosilver, polycarbonate fiber and modified gelatin solution is 1:0.5:0.6:0.09.

[0041] Preparation Example 1-6 The difference from Preparation Example 1-1 is that the mass ratio of chitosan, nanosilver, polycarbonate fiber and modified gelatin solution is 1:0.1:0.9:0.01.

[0042] Preparation Example 1-7 The difference from Preparation Example 1-1 is that no silane coupling agent is added in the preparation method of the modified gelatin solution.

[0043] Preparation Example 1-8 The difference from Preparation Example 1-1 is that no microcrystalline cellulose is added in the preparation method of the modified gelatin solution.

[0044] Preparation Example 1-9 The difference from Preparation Example 1-1 is that the mass ratio of gelatin, silane coupling agent and microcrystalline cellulose is 1:0.3:0.4.

[0045] Preparation Example 1-10 The difference from Preparation Example 1-1 is that the mass ratio of gelatin, silane coupling agent and microcrystalline cellulose is 1:0.7:0.1.

[0046] Preparation example of modified starch Preparation Example 2-1 The preparation method of modified starch comprises the following steps: (1) dispersing 1.2 kg of corn starch in 2 L of 10% sodium hydroxide solution, stirring for 3 h, centrifuging, discarding the supernatant to obtain starch milk, filtering and drying to obtain pretreated corn starch; (2) Disperse the corn starch pretreated in step (1) in 2 L of deionized water, add nano calcium carbonate, beeswax, and 0.2 kg of sodium trimetaphosphate, stir at 70° C. for 3 h, filter, and dry to obtain modified starch.

[0047] The mass ratio of corn starch, nano-calcium carbonate and beeswax is 1:0.2:0.1.

[0048] Preparation Example 2-2 The difference from Preparation Example 2-1 is that in step (2), no nano calcium carbonate is added.

[0049] Preparation Example 2-3 The difference from Preparation Example 2-1 is that in step (2), no beeswax is added.

[0050] Preparation Example 2-4 The difference from Preparation Example 2-1 is that the mass ratio of corn starch, nano-calcium carbonate and beeswax is 1:0.5:0.2.

[0051] Preparation Example 2-5 The difference from Preparation Example 2-1 is that the mass ratio of corn starch, nano-calcium carbonate and beeswax is 1:0.1:0.6. Example

[0052] Example 1 A regenerated oxidized cellulose composite hemostatic material comprises the following raw materials: 10 kg of regenerated oxidized cellulose, 6 kg of modified chitosan, 7 kg of modified starch and 4 kg of calcium alginate fiber.

[0053] The pretreatment method of regenerated oxidized cellulose comprises the following steps: placing commercially available regenerated oxidized cellulose in 16L of 95% by mass ethanol solution, soaking for 25 minutes, taking out, drying, and then washing three times with 75% by mass ethanol solution. After washing, taking out and drying to obtain pretreated regenerated oxidized cellulose, the regenerated oxidized cellulose is purchased from Jilin Chemical Fiber Co., Ltd.

[0054] The preparation method of a regenerated oxidized cellulose composite hemostatic material comprises the following steps: adding modified chitosan, modified starch and calcium alginate fiber into deionized water, stirring for 2 hours at a temperature of 75°C to obtain a mixed solution, adding regenerated oxidized cellulose into the mixed solution, stirring for 1 hour, drying, and grinding to obtain the regenerated oxidized cellulose composite hemostatic material.

[0055] The modified chitosan was prepared according to Preparation Example 1-1, and the modified starch was prepared according to Preparation Example 2-1.

[0056] Example 2 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that it comprises the following raw materials: 15 kg of regenerated oxidized cellulose, 10 kg of modified chitosan, 11 kg of modified starch, and 8 kg of calcium alginate fiber.

[0057] The pretreatment method of regenerated oxidized cellulose comprises the following steps: placing the regenerated oxidized cellulose in 20L of 95% by mass ethanol solution, soaking for 20 minutes, taking out, drying, and then washing 4 times with 75% by mass ethanol solution. After washing, taking out and drying to obtain pretreated regenerated oxidized cellulose.

[0058] The preparation method of a regenerated oxidized cellulose composite hemostatic material comprises the following steps: adding modified chitosan, modified starch and calcium alginate fiber into deionized water, stirring for 3 hours at a temperature of 70°C to obtain a mixed solution, adding regenerated oxidized cellulose into the mixed solution, stirring for 2 hours, drying, and grinding to obtain the regenerated oxidized cellulose composite hemostatic material.

[0059] Example 3 A regenerated oxidized cellulose composite hemostatic material, which is different from Example 1 in that the regenerated oxidized cellulose is purchased from Jilin Chemical Fiber Co., Ltd. without pretreatment.

[0060] Example 4 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared in Preparation Example 1-2.

[0061] Example 5 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared according to Preparation Example 1-3.

[0062] Example 6 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared according to Preparation Examples 1-4.

[0063] Example 7 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared as in Preparation Example 1-5.

[0064] Example 8 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared as in Preparation Example 1-6.

[0065] Example 9 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared in Preparation Example 1-7.

[0066] Example 10 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared in Preparation Example 1-8.

[0067] Embodiment 11 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared as in Preparation Example 1-9.

[0068] Example 12 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified chitosan is prepared according to Preparation Example 1-10.

[0069] Embodiment 13 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that the modified starch adopts the one in Preparation Example 2-2.

[0070] Embodiment 14 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that the modified starch is prepared in Preparation Example 2-3.

[0071] Embodiment 15 A regenerated oxidized cellulose composite hemostatic material, which is different from Example 1 in that the modified starch is prepared in Preparation Example 2-4.

[0072] Example 16 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that the modified starch is prepared in Preparation Example 2-5.

[0073] Embodiment 17 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that a pretreatment method of the regenerated oxidized cellulose comprises the following steps: washing the regenerated oxidized cellulose four times with a 95% by mass ethanol solution, and after washing, taking out and drying to obtain pretreated regenerated oxidized cellulose.

[0074] Embodiment 18 A regenerated oxidized cellulose composite hemostatic material is different from Example 1 in that a pretreatment method of the regenerated oxidized cellulose comprises the following steps: placing the regenerated oxidized cellulose in an ethanol solution with a mass fraction of 75%, soaking for 20-25 minutes, taking out, and drying to obtain pretreated regenerated oxidized cellulose.

[0075] Comparative Example Comparative Example 1 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that modified chitosan is not added.

[0076] Comparative Example 2 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that an equal amount of chitosan is used to replace the modified chitosan.

[0077] Comparative Example 3 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that modified starch is not added.

[0078] Comparative Example 4 A regenerated oxidized cellulose composite hemostatic material, which differs from Example 1 in that an equal amount of starch is used to replace the modified starch.

[0079] Performance testing The regenerated oxidized cellulose composite hemostatic materials prepared in Examples 1-18 and Comparative Examples 1-4 were subjected to performance tests; Water absorption rate: Weigh 20g of sample (W0) and add it into 300mL of distilled water. After the sample swells for 8min until it is saturated with water, centrifuge it at 4500rpm for 10min, remove the upper liquid, and keep the saturated sample. Weigh the mass of the sample after water absorption (W1). Water absorption rate = (W1-W0) / W0×100%.

[0080] Viscosity work index: weigh 1g sample, add water until it is saturated with water to form a condensed water mixture viscous glue, and use a texture analyzer to determine its viscosity work index. The test probe is: P36R (cylindrical probe), the test conditions are room temperature, speed before test: 0.7mm / s; test speed: 1.5mm / s; speed after test: 18mm / s; stress 120g; recovery distance 6.0mm; contact time: 16s; trigger type: automatic-5g.

[0081] Antibacterial test: The antibacterial test was carried out according to the method specified in item C4 of Appendix C of GB15979-2002. The antibacterial species included Staphylococcus aureus (CMCC(B)26003) and Candida albicans (CMCC(F)98001).

[0082] Hemostasis time detection: Specific operation steps: (1) Select 12 healthy New Zealand white rabbits, disinfect the ear vein and slowly inject 3% sodium pentobarbital solution, and conduct the experiment after they are completely anesthetized; (2) Select the central aorta of the rabbit's ear, disinfect the rabbit's ear artery with iodine, and then use a scalpel to make a 1×1 cm wound; (3) After the rabbit's ear artery bleeds, first use ordinary sterile gauze to absorb the blood, and then apply the regenerated oxidized cellulose composite hemostatic material prepared in the embodiment and comparative example to the bleeding wound; (4) Use ordinary sterile gauze to absorb the blood exuding from the wound every 20 seconds, and observe the hemostatic effect; (5) Perform three parallel experiments for each dressing, record the complete hemostasis time respectively, and calculate the average.

[0083] Tensile property test: The regenerated oxidized cellulose prepared in Examples 1-3 and Examples 17-18 were respectively spun into gauze, and an XJJ-10 electrospinning machine was used as a spraying equipment. The regenerated oxidized cellulose was dissolved in distilled water, the syringe temperature was 10°C, the voltage was 40 kV, the nozzle aperture was 0.5 mm, the receiving distance was 22 cm, and the receiving temperature was 20°C. The electrostatic spray was intermittently sprayed 25 times, each time with an interval of 18 min, 1 min / time. The obtained product was vacuum freeze-dried at -55°C for 24 hours to obtain oxidized regenerated cellulose gauze, and then the tensile strength was tested. The test method referred to Part 3 of GB / T24218.3-2010.

[0084] Carboxyl content detection method: titration method.

[0085] 1. Take 1g of sample that has been dried at 90℃ for 2h and put it in a 250mL conical flask. Use a pipette to measure 10mL of 0.5mol / L sodium hydroxide solution and add it. Shake it to dissolve. Add 100mL of water and 2 drops of phenolphthalein. Immediately titrate with 0.1mol / L hydrochloric acid solution until the phenolphthalein is colorless. For blank correction, each mL of 0.1mol / L hydrochloric acid solution is equivalent to 4.50mg of carboxyl (COOH).

[0086] 2. Reagents a) 0.5 mol / L sodium hydroxide solution: weigh 20 g of sodium hydroxide, dissolve it in water, dilute to 1000 mL, and shake well.

[0087] b) Phenolphthalein: Take 1g of phenolphthalein and add 100ml of ethanol to dissolve it.

[0088] c) 0.1 mol / L hydrochloric acid solution titrant: Take 9.0 ml of hydrochloric acid and dilute it to 1000 ml with water, shake well, and standardize according to the pharmacopoeia method.

[0089] 3. Result calculation The carboxyl content is X1, and the value is expressed in %, and is calculated by formula (1): X1=(V1-V2)cM / (1000×m)×100% Where: V1-the volume of 0.1 mol / L hydrochloric acid standard titration solution consumed by the blank, in milliliters (mL); V2-the volume of 0.1 mol / L hydrochloric acid standard titration solution consumed by the sample, in milliliters (mL); c-0.1mol / L hydrochloric acid standard titration solution concentration, the unit is mole per liter (mol / L); m-Numerical value of the mass of the sample, in grams (g): The numerical value of the molar mass of the M-carboxyl group (45) is expressed in grams per mole (g / mol). The test results are shown in Table 1.

[0090] Table 1 Test data of embodiments and comparative examples Table 2 Test data of the embodiment Example 1 Example 2 Example 3 Embodiment 17 Embodiment 18 Tensile strength / MPa 10.78 10.59 6.23 8.45 8.10 Carboxyl content / % 19.68 19.69 19.96 19.72 19.78 Average hemostasis time / s 180 182 195 186 190 Combining the examples and the data in Table 1, it can be seen that the regenerated oxidized cellulose composite hemostatic materials prepared in Examples 1-2, Example 7, Example 11 and Example 15 have good mechanical properties, water absorption, viscosity, antibacterial rate and hemostatic effect. Among them, the water absorption rate of Example 1 is 126 times, the viscosity work index is 261g·sec, the antibacterial rate of Staphylococcus aureus is 100%, the antibacterial rate of Candida albicans is 100%, and the average hemostatic time is 150s, indicating that the various components in the present application cooperate with each other to improve the mechanical properties, water absorption and antibacterial rate of the regenerated oxidized cellulose, and effectively stop bleeding, thereby expanding the application of the regenerated oxidized cellulose composite hemostatic material.

[0091] Example 3 Regenerated oxidized cellulose was purchased from the market without pretreatment. As can be seen from Table 1, compared with Example 1, the water absorption, viscosity and hemostatic effect are all reduced, indicating that the present application pretreats the regenerated oxidized cellulose to improve the stability of the regenerated oxidized cellulose, thereby improving the corresponding performance of the subsequent hemostatic material.

[0092] Among them, the pH of the regenerated oxidized cellulose in Example 3 that has not been pretreated is 2.71, the color is yellow, the surface is glossy, the carboxyl content is 19.96%, and the breaking strength is 0.107 MPa. The pH of the regenerated oxidized cellulose treated with ethanol in Example 1 is 2.83, the color is light yellow, the surface is matte, the carboxyl content is 19.68%, and the breaking strength is 0.514 MPa. It can be seen that the carboxyl content of the regenerated oxidized cellulose treated with ethanol is significantly reduced, the breaking strength is enhanced, and the stability of the regenerated oxidized cellulose is increased, which helps to make the prepared hemostatic material have better hemostatic effect and mechanical properties.

[0093] In Example 17 and Example 18, only ethanol solution was used for washing and only ethanol solution was used for soaking, respectively. As shown in Table 1, compared with Example 1-2, the water absorption, antibacterial property, viscosity and hemostatic effect were all decreased to varying degrees, while various performance indicators were better than those of Example 3, indicating that the pretreatment of the regenerated oxidized cellulose in Example 1 made the regenerated oxidized cellulose have better stability, and the subsequent application in hemostatic materials had better comprehensive performance, while the performance of the regenerated oxidized cellulose in Examples 17-18 was not as good as that in Examples 1-2, so various properties of the corresponding hemostatic materials were also affected.

[0094] The regenerated oxidized cellulose prepared in Examples 1-3 and Examples 17-18 were woven into gauze for mechanical property tests. As can be seen from Table 2, the regenerated oxidized cellulose gauze prepared in Examples 1-2 has excellent mechanical properties, stability and hemostatic effects. The mechanical properties of Example 1 are 10.78 MPa, and the carboxyl content is 19.96%, indicating that the stability of Example 1-2 can be improved after washing with ethanol, thereby making the prepared gauze have good mechanical properties, stability and hemostatic effects. In Example 3, the regenerated oxidized cellulose was not washed with ethanol, and its mechanical properties were significantly reduced, and the carboxyl content was significantly increased. In Examples 17-18, the steps of ethanol washing were changed respectively, and it can be seen that its mechanical properties also decreased accordingly, and the carboxyl content was greater than that of Examples 1-2, but less than that of Example 3, indicating that only the regenerated oxidized cellulose prepared by the ethanol washing process of the present application has better comprehensive properties, thereby improving the application of regenerated oxidized cellulose.

[0095] In the preparation method of modified chitosan in Example 4, nanosilver is not added. As can be seen from Table 1, compared with Example 1, it has a great impact on the antibacterial and hemostatic effects of the hemostatic material, but has little impact on other properties, indicating that nanosilver has good antibacterial and hemostatic properties, improves the corresponding properties of the modified chitosan, and further affects the corresponding properties of the hemostatic material.

[0096] In the preparation methods of modified chitosan in Examples 5-6, polycarbonate fiber and modified gelatin solution are not added respectively. As can be seen from Table 1, compared with Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect are all decreased to varying degrees, indicating that polycarbonate fiber has high strength and toughness and can enhance the physical strength of the hemostatic material. The modified gelatin solution improves the liquid absorption performance and mechanical strength of the quaternized chitosan, and at the same time makes the quaternized chitosan, nanosilver and polycarbonate fiber bond tightly, thereby improving the corresponding performance of the modified chitosan, and subsequently improving the comprehensive performance of the hemostatic material.

[0097] Example 8 changes the mass ratio of chitosan, nanosilver, polycarbonate fiber and modified gelatin solution. It can be seen from Table 1 that, relative to Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect are better than those of Examples 4-6, but worse than those of Examples 1-2, indicating that nanosilver and polycarbonate fiber can be loaded in the structure of chitosan, thereby improving the mechanical properties, antibacterial property and hemostatic effect of chitosan. The modified gelatin solution can coat chitosan, thereby making the quaternized chitosan, nanosilver and polycarbonate fiber adhere tightly, thereby further improving the comprehensive performance of the modified chitosan.

[0098] In the preparation methods of the modified gelatin solutions of Examples 9-10, silane coupling agent and microcrystalline cellulose are not added respectively. As can be seen from Table 1, relative to Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect are worse than those of Examples 1-2, but better than those of Example 6, indicating that the silane coupling agent forms a silicon-containing cross-linked layer on the surface of gelatin to form a more stable network structure, thereby improving the viscosity and mechanical properties of the gelatin solution. Microcrystalline cellulose has good viscosity and is mixed with gelatin to increase the viscosity of the gelatin solution, which is helpful for the subsequent application of the gelatin solution in the modified chitosan, thereby improving the coating property of the gelatin on the modified chitosan, and then subsequently improving the corresponding performance of the hemostatic material.

[0099] Example 12 changes the mass ratio of gelatin, silane coupling agent and microcrystalline cellulose. It can be seen from Table 1 that, relative to Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect are better than those of Examples 9-10, but worse than those of Examples 1-2, indicating that there is a synergistic effect between gelatin, silane coupling agent and microcrystalline cellulose, which is subsequently applied to modified chitosan to improve the coating property of gelatin on modified chitosan, thereby improving the mechanical strength and hemostatic effect of modified chitosan.

[0100] In the preparation methods of modified starches in Examples 13-14, nano-calcium carbonate and beeswax are not added respectively. As can be seen from Table 1, compared with Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect are all decreased to varying degrees, indicating that nano-calcium carbonate can be loaded in the structure of corn starch to improve the structural strength of corn starch, and beeswax can coat corn starch to improve the toughness of corn starch, thereby subsequently improving the comprehensive properties of the hemostatic material such as the mechanical properties.

[0101] Example 16 changes the mass ratio of corn starch, nano-calcium carbonate and beeswax. As can be seen from Table 1, relative to Example 1, the water absorption, antibacterial, viscosity and hemostatic effect are better than those of Examples 13-14, but worse than those of Examples 1-2, indicating that nano-calcium carbonate can be loaded in the structure of corn starch to improve the structural strength of corn starch, and beeswax coats corn starch to improve the toughness of corn starch, so that nano-calcium carbonate and corn starch are more closely connected, which can be subsequently applied to hemostatic materials to improve the mechanical strength and hemostatic effect of the hemostatic materials.

[0102] No modified chitosan was added in Comparative Example 1, and no modified starch was added in Comparative Example 3. As can be seen from Table 1, relative to Example 1, the water absorption, antibacterial property, viscosity and hemostatic effect were significantly worse than those of Examples 1-2, indicating that the modified chitosan and starch of the present application have better mechanical strength, antibacterial property, viscosity and hemostatic effect, thereby improving the corresponding performance of the hemostatic material.

[0103] Comparative Example 2 and Comparative Example 4 respectively use an equal amount of chitosan to replace the modified chitosan and an equal amount of starch to replace the modified starch. As can be seen from Table 1, relative to Example 1, the water absorption, antibacterial properties, viscosity and hemostatic effects are significantly worse than those of Examples 1-2, and better than those of Comparative Example 1 and Comparative Example 3, indicating that the modified chitosan and starch of the present application have better comprehensive properties, and are subsequently applied to hemostatic materials to improve the corresponding properties of the hemostatic materials.

[0104] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.

Claims

1. A regenerated oxidized cellulose composite hemostatic material, characterized in that: The invention comprises the following raw materials: 10-15 parts of regenerated oxidized cellulose, 6-10 parts of modified chitosan, 7-11 parts of modified starch and 4-8 parts of calcium alginate fiber.

2. The regenerated oxidized cellulose composite hemostatic material according to claim 1, characterized in that: The method for pretreating regenerated oxidized cellulose comprises the following steps: placing the regenerated oxidized cellulose in an ethanol solution, soaking for 20-25 minutes, taking it out, drying it, and then washing it with the ethanol solution for 3-4 times. After washing, taking it out and drying it to obtain the pretreated regenerated oxidized cellulose.

3. The regenerated oxidized cellulose composite hemostatic material according to claim 1, characterized in that: The preparation method of the modified chitosan comprises the following steps: (1) Dispersing chitosan in acetic acid solution, adding trimethylammonium glycidyl chloride, heating and reacting at 70-75°C for 8-10 hours to obtain quaternized chitosan; (2) adding nanosilver and polycarbonate fiber to the quaternized chitosan obtained in step (1), stirring at a temperature of 60-65° C. for 1-2 h, filtering, and drying to obtain a mixture; (3) Spraying the surface of the mixture obtained in step (2) with a modified gelatin solution, drying, and grinding to obtain modified chitosan.

4. The regenerated oxidized cellulose composite hemostatic material according to claim 3, characterized in that: The mass ratio of the chitosan, nano silver, polycarbonate fiber and modified gelatin solution is 1:0.2-0.5:0.3-0.6:0.07-0.

09.

5. The regenerated oxidized cellulose composite hemostatic material according to claim 3, characterized in that: The preparation method of the modified gelatin solution comprises the following steps: dissolving gelatin in deionized water, stirring at a temperature of 80-85° C. for 1-2 hours, adding a silane coupling agent, acetic acid and microcrystalline cellulose, and continuing stirring to obtain a modified gelatin solution.

6. The regenerated oxidized cellulose composite hemostatic material according to claim 5, characterized in that: The mass ratio of the gelatin, the silane coupling agent and the microcrystalline cellulose is 1:0.1-0.3:0.4-0.

7.

7. The regenerated oxidized cellulose composite hemostatic material according to claim 1, characterized in that: The preparation method of the modified starch comprises the following steps: (1) Dispersing corn starch in sodium hydroxide solution, stirring for 2-3 hours, centrifuging, discarding the supernatant to obtain starch milk, filtering and drying to obtain pretreated corn starch; (2) Dispersing the pretreated corn starch in step (1) in deionized water, adding nano calcium carbonate, beeswax and sodium trimetaphosphate, stirring at a temperature of 65-70° C. for 2-3 h, filtering and drying to obtain modified starch.

8. The regenerated oxidized cellulose composite hemostatic material according to claim 7, characterized in that: The mass ratio of the corn starch, nano-calcium carbonate and beeswax is 1:0.2-0.5:0.1-0.

2.

9. The method for preparing a regenerated oxidized cellulose composite hemostatic material according to claim 1, characterized in that: The method comprises the following steps: adding modified chitosan, modified starch and calcium alginate fiber into deionized water, stirring for 2-3 hours at a temperature of 70-75°C to obtain a mixed solution, adding regenerated oxidized cellulose into the mixed solution, stirring for 1-2 hours, drying, grinding, and obtaining a regenerated oxidized cellulose composite hemostatic material.

10. Use of the regenerated oxidized cellulose composite hemostatic material according to any one of claims 1 to 9 in in vivo medical devices.

Citation Information

Cited By

  • Bio-based degradable efficient antibacterial medical dressing and preparation method thereof

    CN122461530A

  • A biobased degradable high-efficiency antibacterial medical dressing and a preparation method thereof

    CN122461530B